SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Elicera Therapeutics Secures Chinese Patent Allowance for ELC-401

The patent allowance covers Elicera Therapeutics’ glioblastoma therapy ELC-401 in China.

Related stories